NHUNG HO: Open Payments
NPI 1285166397 · KIRKLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,463 in 147 payments from 16 companies in 2025. Trend: 2023 $5,149 · 2024 $4,076 · 2025 $3,463
Food & beverage: $3,259Education: $204
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 38 | $758 |
| Regeneron Healthcare Solutions, Inc. | 8 | $492 |
| GENZYME CORPORATION | 11 | $399 |
| Janssen Biotech, Inc. | 16 | $374 |
| E.R. Squibb & Sons, L.L.C. | 10 | $266 |
| ABBVIE INC. | 19 | $256 |
| Galderma Laboratories, L.P. | 8 | $245 |
| Novartis Pharmaceuticals Corporation | 15 | $168 |
| Arcutis Biotherapeutics, Inc. | 12 | $168 |
| LEO Pharma Inc. | 2 | $135 |
Products named: DUPIXENT, OPZELURA, TREMFYA, Sotyktu, NEMLUVIO, COSENTYX, Zoryve, RINVOQ.
Industry payments across WA — which companies pay providers there.
